4//SEC Filing
Claypoole Robert E 4
Accession 0001578563-24-000014
CIK 0001665988other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:52 PM ET
Size
7.8 KB
Accession
0001578563-24-000014
Insider Transaction Report
Form 4
Claypoole Robert E
DirectorPresident and CEO
Transactions
- Award
Restricted Stock Units
2024-01-11+375,000→ 375,000 total→ Class A Common Stock (375,000 underlying) - Award
Stock Option (Right to Buy)
2024-01-11+850,000→ 850,000 totalExercise: $4.89Exp: 2034-01-11→ Class A Common Stock (850,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0002005474
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:52 PM ET
- Size
- 7.8 KB